Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00602953 · ClinicalTrials.gov registry record
Role of Pancreatic Triglyceride Content in Beta-cell Function
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 101
- Enrollment target
NCT00602953: Completed study, sponsored by University of Texas Southwestern Medical Center.
NCT00602953 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 101 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00602953 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 101 participants
- Enrollment target
Study Summary
The study evaluates if fat accumulates in the pancreas in individuals at risk of developing obesity-related diabetes. It also evaluates if the amount of fat in the pancreas can predict the residual functional capacity of the pancreas (insulin secretion).
Primary Outcome
Pancreatic and liver triglyceride (fat) content measured by the magnetic resonance spectroscopy (MRS) technique in volunteers with a wide range of body mass index (BMI).
Interventions
- OTHER No intervention planned.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2007-09 |
| Est. Completion | 2012-08 |
What the finished NCT00602953 record still lists
NCT00602953 is an observational study that tracks outcomes without assigning an intervention. The registered 101 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which No intervention planned. is the first listed.
NCT00602953 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00602953 about?
NCT00602953 is a clinical study titled "Role of Pancreatic Triglyceride Content in Beta-cell Function". The study evaluates if fat accumulates in the pancreas in individuals at risk of developing obesity-related diabetes. It also evaluates if the amount of fat in the pancreas can predict the residual functional capacity of the pancreas (insulin secretion).
What is the current status of trial NCT00602953?
This trial is currently completed. The enrollment target is 101 participants. The study started on 2007-09. Estimated completion is 2012-08.
What interventions are being tested in trial NCT00602953?
The interventions under investigation include: No intervention planned. (OTHER).
Who is sponsoring clinical trial NCT00602953?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04033497 · 101 participants · NA
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
- NCT05111574 · 101 participants · Phase 2
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
- NCT05984680 · 101 participants
COPD Care Pathway Among Patients With Cancer
- NCT06266299 · 101 participants · Phase 1
A Study of KK2269 in Adult Participants With Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia